T cells from patients with systemic lupus erythematosus express decreased levels of the T cell receptor-associated CD3 chain, a feature directly linked to their aberrant function. The decrease in CD3 protein expression is in part due to decreased levels of functional wild type isoform of the 3-untranslated region (UTR) of CD3 mRNA with concomitant increased levels of an unstable alternatively spliced isoform. In order to identify factors involved in the post-transcriptional regulation of CD3, we performed mass spectrometric analysis of Jurkat T cell nuclear proteins "pulled down" by a CD3 3-UTR oligonucleotide, which identified the splicing protein alternative splicing factor/splicing factor 2 (ASF/SF2). We show for the first time that ASF/SF2 binds specifically to the 3-UTR of CD3 and regulates expression of CD3 protein by limiting the production of the alternatively spliced isoform. During activation of human T cells, an increase in the wild type CD3 mRNA is associated with increased expression of ASF/SF2. Finally, we show a significant correlation between ASF/SF2 and CD3 protein levels in T cells from systemic lupus erythematosus patients. Thus, our results identify ASF/SF2 as a novel factor in the regulation of alternative splicing of the 3-UTR of CD3 and protein expression in human T cells.
Systemic lupus erythematosus (SLE)2 is a chronic multisystem autoimmune disease characterized by abnormal cellular and humoral immune responses and a disease course marked by relapses (flares) and remissions. A key signaling defect of T cells in SLE patients is their aberrant expression of the T cell receptor (TCR)-associated CD3 chain, the crucial signaling transducer of the TCR (1). CD3 protein expression is heterogeneous in SLE patients and tends to inversely correlate with severity of the disease. Consequently, many patients exhibit decreased (20 -80% of normal) levels of CD3 protein, whereas others express normal levels of CD3 protein when compared with healthy individuals. The homologous Fc receptor ␥ chain replaces CD3 chain in the TCR CD3 complex in these CD3-low T cells (2) and recruits the spleen tyrosine kinase (Syk) instead of the normally recruited -associated protein (ZAP-70) (3). This "rewiring" of the TCR, along with preclustered TCRbearing lipid rafts, leads to aberrantly increased phosphorylation and calcium flux upon activation (4). Despite this overexcitable phenotype, SLE T cells fail to produce the vital cytokine interleukin-2. Replenishment of the CD3 in the SLE T cells in vitro reverts this phenotype and more importantly restores interleukin-2 production (5). Although these findings highlight a central role for the aberrant CD3 expression in the SLE T cell defect, the mechanisms regulating the expression of CD3 chain in physiology and in disease are not fully understood.The CD3 gene spans 31 kb in the chromosome 1q23.1 locus, a region associated with SLE susceptibility (6), and bears eight exons separated by introns ranging from 700 bp to greater than 8 kb (Fig. 1A, top) (7,8). The CD3 mRNA is a 1...